During the past decade, Providence ALS Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence ALS Center" #1 sponsor was "Cytokinetics" with 6 trials, followed by "Knopp Biosciences" with 2 trials sponsored, "Barrow Neurological Institute" with 1 trials sponsored, "Biogen" with 1 trials sponsored and "Center for Neurologic Study, La Jolla, California," with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence ALS Center" #1 collaborator was "ALS Association" with 3 trials as a collaborator, "Muscular Dystrophy Association" with 2 trials as a collaborator, "ALS Therapy Alliance" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Providence ALS Center" are "Amyotrophic Lateral Sclerosis" (15 trials), "Amyotrophic Lateral Sclerosis (ALS)" (2 trials), "Hereditary Spastic Paraparesis" (1 trials), "Lou Gehrig's Disease" (1 trials) and "Nervous System Diseases" (1 trials). Many other conditions were trialed in "Providence ALS Center" in a lesser frequency.

Most popular intervention types in "Providence ALS Center" are "Drug" (15 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "CK-2017357" (2 trials), "Dexpramipexole" (2 trials), "Placebo tablets" (2 trials) and "Reldesemtiv" (2 trials). Other intervention names were less common.

The vast majority of trials in "Providence ALS Center" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Providence ALS Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Providence ALS Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Providence ALS Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".